Sonendo Inc (SONX)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Sonendo, Inc. Reports Second Quarter 2024 Financial Results and Raises Full Year Revenue Guidance

Sonendo, Inc. (“Sonendo” or the “Company”) (OTCQX: SONX), a leading dental technology company and developer of the GentleWave® System, today...

Sonendo, Inc. to Report Second Quarter 2024 Financial Results on August 7, 2024

Sonendo, Inc. (“Sonendo”) (OTCQX: SONX), a leading dental technology company and developer of the GentleWave® System, today announced that it...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

Sonendo Strengthens Leadership With Key Strategic Appointments

John Bostjancic Appointed as Chief Financial Officer Bob Guyatt Appointed as Senior Vice President of Marketing John McGaugh Promoted to Senior...

Form 4 - Statement of changes in beneficial ownership of securities

Sonendo to Present at the 2024 Stifel Jaws & Paws Conference

Sonendo, Inc. (OTCQX: SONX), a leading dental technology company and developer of the GentleWave® System, today announced that management will...

Sonendo, Inc. Reports First Quarter 2024 Financial Results and Announces Strategic Reset Priorities

Sonendo, Inc. (OTCQX: SONX) (“Sonendo”), a leading dental technology company and developer of the GentleWave® System, today reported financial...

Form ARS - Annual Report to Security Holders

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form DEF 14A - Other definitive proxy statements